• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Mt Gox Resumes Bitcoin Transfers Amid Deadline Pressure

chest

Mt Gox has resumed Bitcoin transfers to facilitate repayments to creditors, with a deadline set for October 31, 2026.

user avatarMaria Fernandez

XRP Whales Withdraw from Binance, Halting Selloffs

chest

XRP whales are withdrawing from Binance, leading to a significant drop in selloffs on the platform.

user avatarGustavo Mendoza

Bitcoin Price Crash and Future Predictions

chest

Bitcoin has recently crashed below the $70,000 mark, with market analyst Crypto Patel predicting further declines, potentially reaching $50,000.

user avatarRajesh Kumar

Peter Todd Raises Concerns Over Zcash-Style Privacy in Bitcoin

chest

Bitcoin developer Peter Todd opposes incorporating Zcash-style privacy features into Bitcoin, citing cryptographic risks and emphasizing the need for transparency.

user avatarMiguel Rodriguez

Anthropic's Report Reveals AI's Potential for Self-Improvement

chest

A new report by Anthropic reveals that AI systems, particularly Claude, are significantly contributing to software development and may lead to recursive self-improvement.

user avatarLuis Flores

Israel's Crypto Disclosure Program Sees Disappointing Participation

chest

Only 58 individuals participated in Israel's voluntary crypto disclosure program, falling significantly short of expectations.

user avatarArif Mukhtar

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.